3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
15
Recurrence
8
Hodgkin Disease
6
Breast Neoplasms
6
Lymphoma, Large B-Cell, Diffuse
5
Sezary Syndrome
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Mycosis Fungoides
4
Leukemia, Myeloid, Acute
4
Leukemia
4
Waldenstrom Macroglobulinemia
3
Neoplasms
3
Myelodysplastic Syndromes
3
Lymphoma, T-Cell, Cutaneous
3
Lymphoma, Non-Hodgkin
3
Lymphoma, Mantle-Cell
3
Lymphoma
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Prostatic Neoplasms
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Neoplasm Metastasis
2
Melanoma
2
Lymphoma, Large-Cell, Anaplastic
2
Lymphoma, Follicular
2
Lymphoma, Extranodal NK-T-Cell
2
Lymphoma, B-Cell, Marginal Zone
2
Immunoblastic Lymphadenopathy
2
Glioma
2
Diffuse Intrinsic Pontine Glioma
2
Carcinoma, Renal Cell
2
Interventions
Carboplatin
42
Etoposide
37
Cisplatin
23
Topotecan
22
Nivolumab
17
pembrolizumab
12
atezolizumab
12
Ipilimumab
10
Paclitaxel
9
durvalumab
8
Irinotecan
8
Radiosurgery
6
Pemetrexed
6
rovalpituzumab tesirine
5
Magnetic Resonance Spectroscopy
5
trioctyl phosphine oxide
4
trilaciclib
4
etoposide phosphate
4
berzosertib
4
Sunitinib
4
Specimen Handling
4
Platinum
4
PM 01183
4
Dexamethasone
4
veliparib
3
tremelimumab
3
olaparib
3
carfilzomib
3
cabozantinib
3
Temozolomide
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Small Cell Lung Carcinoma
×
Panobinostat
×
Clear all
No trials found.